Coronavirus/COVID-19, Competition

Regulatory Escalation in Pharma Sector: China Imposes First Executive Sanctions in a Cartel Case

Dacheng on 5/27/2025

On May 9, 2025, the Tianjin Municipal Administration for Market Regulation (“Tianjin AMR”) announced administrative penalties against four manufacturers of dexamethasone sodium phosphate (“DSP”) active pharmaceutical...more

Rising Costs from High Inflation and Interest Rates Contribute to a Continued Increase in Large Corporate Bankruptcy Filings...

Cornerstone Research on 10/4/2024

Filings in the services, manufacturing, finance, insurance, and real estate industries contribute to year-over-year increase. Large corporate bankruptcy filings continued to climb in the latter half of 2023 through the first...more

EU Emergency Response Update – Key Policy & Regulatory Developments No. 109

Jones Day on 12/20/2023

This regular alert covers key regulatory developments related to EU emergency responses, including in particular to Russia’s war of aggression against Ukraine, COVID-19, and cyber threats. It does not purport to provide an...more

Thankful for Pharmaceuticals . . . Especially When There are Shortages

Axinn, Veltrop & Harkrider LLP on 11/21/2023

5 When our children were young, we started a tradition at Thanksgiving of going around the table and having each of us (around 20 with extended family) saying what we were thankful for. Of course, you hear a lot of being...more

EU Emergency Response Update – Key Policy & Regulatory Developments No. 108

Jones Day on 11/20/2023

This regular alert covers key regulatory developments related to EU emergency responses, including in particular, to COVID-19, Russia’s war of aggression against Ukraine, and cyber threats. It does not purport to provide an...more

EU Emergency Response Update – Key Policy & Regulatory Developments No. 107

Jones Day on 10/24/2023

This regular alert covers key regulatory developments related to EU emergency responses, including in particular, to COVID-19, Russia’s war of aggression against Ukraine, and cyber threats. It does not purport to provide an...more

EU Emergency Response Update – Key Policy & Regulatory Developments No. 106

Jones Day on 10/4/2023

This regular alert covers key regulatory developments related to EU emergency responses, including in particular, to COVID-19, Russia’s war of aggression against Ukraine, and cyber threats. It does not purport to provide an...more

Meatpacking Scrutiny Accelerates as Senate Considers New Antitrust Bill

Vinson & Elkins LLP on 9/21/2023

On September 14, 2023, Senator Josh Hawley of Missouri introduced the Strengthening Antitrust Enforcement for Meatpacking Act of 2023, an ambitious new piece of legislation designed to halt consolidation in the meatpacking...more

EU Emergency Response Update - Key Policy & Regulatory Developments No. 105

Jones Day on 9/18/2023

This regular alert covers key regulatory developments related to EU emergency responses, including in particular, to COVID-19, Russia’s war of aggression against Ukraine, and cyber threats. It does not purport to provide an...more

[Webinar] The mRNA/Lipid Nanoparticle Competitive and Litigation Landscape - September 27th, 2:00 pm ET

Rothwell, Figg, Ernst & Manbeck, P.C. on 8/22/2023

Partner Dan Shores will present a webinar titled "The mRNA/Lipid Nanoparticle Competitive and Litigation Landscape" for Medmarc, the leading expert in the products liability risks facing medical technology and life sciences...more

EU Emergency Response Update – Key Policy & Regulatory Developments No. 104

Jones Day on 8/15/2023

This regular alert covers key regulatory developments related to EU emergency responses, including in particular, to COVID-19, Russia’s war of aggression on against Ukraine, and cyber threats. It does not purport to provide...more

EU Emergency Response Update – Key Policy & Regulatory Developments No. 103

Jones Day on 7/21/2023

This regular alert covers key regulatory developments related to EU emergency responses, including in particular, to COVID-19, Russia’s war of aggression on against Ukraine, and cyber threats. ...more

EU Emergency Response Update – Key Policy & Regulatory Developments No. 102

Jones Day on 6/15/2023

This regular alert covers key regulatory developments related to EU emergency responses, including in particular, to COVID-19, Russia’s war of aggression on against Ukraine, and cyber threats. It does not purport to provide...more

Are your employees working more than one job?

Constangy, Brooks, Smith & Prophete, LLP on 5/31/2023

The pandemic altered some employment norms. The COVID-19 pandemic has altered a variety of employment norms. There is considerable debate about which changes are transient and which are more durable, particularly given...more

EU Emergency Response Update – Key Policy & Regulatory Developments No. 101

Jones Day on 5/19/2023

This regular alert covers key regulatory developments related to EU emergency responses, including in particular, to COVID-19, Russia’s war of aggression on against Ukraine, and cyber threats. It does not purport to provide...more

EU Emergency Response Update – Key Policy & Regulatory Developments No. 100

Jones Day on 5/5/2023

This alert covers key regulatory developments related to EU emergency responses, including in particular, to COVID-19, Russia’s war of aggression on against Ukraine, and cyber threats. It does not purport to provide an...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 99

Jones Day on 4/17/2023

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. This COVID-19 Update...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 98

Jones Day on 3/22/2023

This regular update (no. 98 | 1 March 2023) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 97

Jones Day on 3/7/2023

This regular update (no. 97 | 14 February 2023) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal...more

Scrutiny for the Private Sector Will Come from Both Sides of the Aisle in the 118th Congress

Foley Hoag LLP - White Collar Law &... on 2/23/2023

This is the fourth part in our 2023 series examining important trends in white collar law and investigations. Up next: SEC. Last year, as we laid out the landscape for congressional investigations in 2022, we noted that...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 96

Jones Day on 2/14/2023

This regular update (no. 96 | 27 January 2023) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective...more

Client Alert: Ten Major Issues Facing Higher Education Institutions in 2023

Jenner & Block on 2/3/2023

The last few years have been eventful and, at times, difficult ones for institutions of higher education. Institutions have been deeply impacted by issues ranging from the COVID-19 pandemic, to debates over free speech, to...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 95

Jones Day on 1/31/2023

This regular update (no. 95 | 9 January 2023) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 94

Jones Day on 1/19/2023

This regular update (no. 94 | 19 December 2022 ) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 93

Jones Day on 12/27/2022

This regular update (no. 93| 1 December 2022 ) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective...more

Coronavirus/COVID-19 › Competition

"My best business intelligence, in one easy email…"